Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intellia Therapeutics (NTLA) Non Operating Investment Income: 2018-2024

Historic Non Operating Investment Income for Intellia Therapeutics (NTLA) over the last 7 years, with Dec 2024 value amounting to -$32.6 million.

  • Intellia Therapeutics' Non Operating Investment Income fell 22.75% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$429,000, marking a year-over-year increase of 97.85%. This contributed to the annual value of -$32.6 million for FY2024, which is 995.87% down from last year.
  • According to the latest figures from FY2024, Intellia Therapeutics' Non Operating Investment Income is -$32.6 million, which was down 995.87% from $3.6 million recorded in FY2023.
  • In the past 5 years, Intellia Therapeutics' Non Operating Investment Income ranged from a high of $3.6 million in FY2023 and a low of -$32.6 million during FY2024.
  • In the last 3 years, Intellia Therapeutics' Non Operating Investment Income had a median value of -$1.6 million in 2022 and averaged -$10.2 million.
  • Per our database at Business Quant, Intellia Therapeutics' Non Operating Investment Income spiked by 322.05% in 2023 and then plummeted by 995.87% in 2024.
  • Intellia Therapeutics' Non Operating Investment Income (Yearly) stood at -$260,000 in 2020, then slumped by 717.69% to -$2.1 million in 2021, then climbed by 23.00% to -$1.6 million in 2022, then surged by 322.05% to $3.6 million in 2023, then plummeted by 995.87% to -$32.6 million in 2024.